Amneal Pharmaceuticals, Inc. Class A Common Stock
Drug Manufacturers - Specialty & Generic
Healthcare
AMRX
324 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
10.09
52 week high
10.09
high
10.16
52 week low
0.00
low
9.83
growth
13.10 %
previous Close
10.00
P/E ratio
market cap
3.92 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
0.00 %
-1.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top